Environmental Microbial Communities Living Under Very High Antibiotic Selection Pressure

Antimicrobial Resistance in the Environment

Volumn , Issue , 2011, Pages 483-501

  Janzon, Anders ^a,b   Kristiansson, Erik ^b,c   Larsson, D G Joakim ^b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Anthropogenic antibiotics in microbial ecosystems, antibiotic resistance risk; Microbial communities, and high antibiotic selection pressure; Very high levels of antibiotics in environment, effects, consequences

Indexed keywords

EID: 84886411037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118156247.ch25     Document Type: Chapter

References (79)

1. Al-Ahmad A, Daschner FD, Kummerer K (1999). Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin g, and sulfamethoxazole and inhibition of wastewater bacteria. Arch Environ Contam Toxicol 37(2):158-163.
2. Al-Ahmad A, Haiss A, Unger J, Brunswick-Tietze A, Wiethan J, Ku mmerer K (2009). Effects of a realistic mixture of antibiotics on resistant and nonresistant sewage sludge bacteria in laboratory-scale treatment plants. Arch Environ Contam Toxicol 57(2):264-273.
3. Allen HK, Moe LA, Rodbumrer J, Gaarder A, Handelsman J (2009). Functional metagenomics reveals diverse beta-lactamases in a remote alaskan soil. ISME J 3(2):243-251.
4. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J (2010). Call of the wild: Antibiotic resistance genes in natural environments. Nat Rev Microbiol 8(4):251-259.
5. Babic S, Mutavdzic D, Asperger D, Horvat AJM, and Kastelan-Macan M (2007). Determination of veterinary pharmaceuticals in production wastewater by hptlc-videodensitometry. Chromatographia 65(1-2):105-110.
6. Batt AL, Kim S, Aga DS (2007). Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plantswith varying designs and operations. Chemosphere 68(3):428-435.
7. Bean DC, Livermore DM, Hall LMC (2009). Plasmids imparting sulfonamide resistance in Escherichia coli: Implications for persistence. Antimicrob Agents Chemother 53(3): 1088-1093.
8. Bjorklund HV, Rabergh CMI, and Bylund G (1991). Residues of oxolinic acid and oxytetracycline in fish and sediments from fish farms. Aquaculture 97(1):85-96.
9. Boerlin P, Reid-Smith RJ (2008). Antimicrobial resistance: Its emergence and transmission. Anim Health Res Rev 9(2):115-126.
10. Brazas MD, Hancock REW (2005). Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(8):3222-3227.
11. Campagnolo ER, Johnson KR, Karpati A, Rubin CS, Kolpin DW, Meyer MT, Esteban JE, Currier RW, Smith K, Thu KM, McGeehin M (2002). Antimicrobial residues in animal waste and water resources proximal to large-scale swine and poultry feeding operations. Sci Total Environ 299(1-3):89-95.
12. Canton R (2009). Antibiotic resistance genes from the environment: A perspective through newly identified antibiotic resistance mechanisms in the clinical setting. Clin Microbiol Infect 15 Suppl 1 :20-25.
13. Christian T, Schneider RJ, Farber HA, Skutlarek D, Meyer MT, Goldbach HE (2003). Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydrochim Hydrobiol 31(1):36-44.
14. Cordova-Kreylos AL, Scow KM (2007). Effects of ciprofloxacin on salt marsh sediment microbial communities. ISME J 1(7):585-595.
15. Coyne R, Hiney M, Oconnor B, Kerry J, Cazabon D, Smith P (1994). Concentration and persistence of oxytetracycline in sediments under a marine salmon farm. Aquaculture 123(1-2):31-42.
16. D'Costa VM, McGrann KM, Hughes DW, Wright GD (2006). Sampling the antibiotic resistome. Science 311(5759):374-377.
17. D'Costa VM, Griffiths E, Wright GD (2007). Expanding the soil antibiotic resistome: Exploring environmental diversity. Curr Opin Microbiol 10(5):481-489.
18. Davies J, Spiegelman GB, Yim G (2006). The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9(5):445-453.
19. Dethlefsen L, Relman DA (2011). Microbes and health sackler colloquium: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108(supplement 1):4554-4561.
20. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rrna sequencing. PLoS Biol 6(11): 2383-2400.
21. de With K, Schroder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kammerer R, Ruess S, Daschner FD, Kern WV (2004). Antibiotic use in Germany and Europe. Dtsch Med Wochenschr 129(38):1987-1992.
22. Diwan V, Tamhankar AJ, Khandal RK, Sen S, Aggarwal M, Marothi Y, Iyer RV, Sundblad- Tonderski K, Stalsby-Lundborg C (2010). Antibiotics and antibiotic-resistant bacteria in waters associated with a hospital in Ujjain, India. BMC Public Health 10:414.
23. Dokianakis SN, Kornaros ME, Lyberatos G (2004). On the effect of pharmaceuticals on bacterial nitrite oxidation. Water Sci Technol 50(5):341-346.
24. Donato JJ, Moe LA, Converse BJ, Smart KD, Berklein FC, McManus PS, Handelsman J (2010). Metagenomic analysis of apple orchard soil reveals antibiotic resistance genes encoding predicted bifunctional proteins. Appl Environ Microbiol 76(13):4396-4401.
25. Duong HA, Pham NH, Nguyen HT, Hoang TT, Pham HV, Pham VC, Berg M, Giger W, Alder AC (2008). Occurrence, fate and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi, Vietnam. Chemosphere 72(6):968-973.
26. Fick J, Soderstrom H, Lindberg RH, Phan C, Tysklind M, Larsson DGJ (2009). Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 28(12):2522-2527.
27. Froehner K, Backhaus T, Grimme LH (2000). Bioassays with Vibrio fischeri for the assessment of delayed toxicity. Chemosphere 40(8):821-828.
28. Giger W, Alder AC, Golet EM, Kohler HPE, McArdell CS, Molnar E, Siegrist H, Suter MJF (2003). Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters. Chimia 57(9):485-491.
29. Gobel A, Thomsen A, Mcardell CS, Joss A, Giger W (2005). Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 39(11):3981-3989.
30. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J (2002). Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 99(26):17025-17030.
31. Gomez J, Mendez R, Lema JM (1996). The effect of antibiotics on nitrification processes- Batch assays. Appl Biochem Biotechnol 57-58:869-876.
32. Gulkowska A, Leung HW, So MK, Taniyasu S, Yamashita N, Yeunq LWY, Richardson BJ, Lei AP, Giesy JP, Lam PKS (2008). Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. WaterRes 42(1-2):395-403.
33. Holm JV, Bjerg PL, Rugge K, Christensen TH (1995). Occurrence and distribution of pharmaceutical organic-compounds in the groundwater downgradient of a landfill (Grindsted, Denmark)-response. Environ Sci Technol 29(12):3074-3074.
34. Hugenholtz P, Goebel BM, Pace NR (1998). Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180(24):6793-6793.
35. Hurlbert SH (1971). Nonconcept of species diversity-critique and alternative parameters. Ecology 52(4):577-587.
36. Jacobsen P, Berglind L (1988). Persistence of oxytetracycline in sediments from fish farms. Aquaculture 70(4):365-370.
37. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L (2010). Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5(3).
38. Jarnheimer PA, Ottoson J, Lindberg R, Stenstrom TA, Johansson M, Tysklind M, Winner MM, Olsen B (2004). Fluoroquinolone antibiotics in a hospital sewage line; occurrence, distribution and impact on bacterial resistance. Scand J Infect Dis 36(10): 752-755.
39. Jjemba PK (2006). Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 63(1):113-130.
40. Karthikeyan KG, Meyer MT (2006). Occurrence of antibiotics in wastewater treatment facilities in wisconsin, USA. Sci Total Environ 361(1-3):196-207.
41. Kazimierczak KA, Rincon MT, Patterson AJ, Martin JC, Young P, Flint HJ, Scott KP (2008). New tetracycline efflux gene, tet(40), is located in tandem with tet(o/32/o) in a human gut firmicute bacterium and in metagenomic library clones. Antimicrob Agents Chemother 52 (11):4001-4009.
42. Knapp CW, Dolfing J, Ehlert PAI, Graham DW (2010). Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol 44(2): 580-587.
43. Kristiansson E, Hugenholtz P, and Dalevi D (2009). Shotgunfunctionalizer: An r-package for functional comparison of metagenomes. Bioinformatics 25(20):2737-2738.
44. Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdega° rd B, Soderstrom H, Larsson DGJ (2011). Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS ONE 6(2):e17038.
45. Ku mmerer K (2009a). Antibiotics in the aquatic environment-A review-Part I. Chemosphere 75(4):417-434.
46. Ku mmerer K (2009b). Antibiotics in the aquatic environment-A review-Part II. Chemosphere 75(4):435-441.
47. Ku mmerer K, Alexy R, Huttig J, Scholl A (2004). Standardized tests fail to assess the effects of antibiotics on environmental bacteria. Water Res 38(8):2111-2116.
48. Lang KS, Anderson JM, Schwarz S, Williamson L, Handelsman J, Singer RS (2010). Novel florfenicol and chloramphenicol resistance gene discovered in Alaskan soil by using functional metagenomics. Appl Environ Microbiol 76(15):5321-5326.
49. Larsson DJ (2010). Release of active pharmaceutical ingredients from manufacturing sites- need for new management strategies. Integr Environ Assess Manag 6(1):184-186.
50. Larsson DGJ, Fick J (2009). Transpararency throughout the production chain-a way to reduce pollution from the manufacturing of pharmaceuticals. Regul Toxicol Pharmacol 53:161-163.
51. Larsson DGJ, de Pedro C, Paxeus N (2007). Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148(3):751-755.
52. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005). Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070-11075.
53. Li D, Yang M, Hu J, Ren L, Zhang Y, Li K (2008a). Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ Toxicol Chem 27(1):80-86.
54. Li D, Yang M, Hu JY, Zhang Y, Chang H, Jin F (2008b). Determination of penicillin g and its degradation products in a penicillin production wastewater treatment plant and the receiving river. Water Res 42(1-2):307-317.
55. Li D, Yang M, Hu JY, Zhang J, Liu RY, Gu X, Zhang Y, Wang ZY (2009). Antibioticresistance profile in environmental bacteria isolated from penicillin production wastewater treatment plant and the receiving river. Environ Microbiol 11(6):1506-1517.
56. Li D, Yu T, Zhang Y, Yang M, Li Z, Liu MM, Qi R (2010). Antibiotic resistance characteristics of environmental bacteria from an oxytetracycline production wastewater treatment plant and the receiving river. Appl Environ Microbiol 76(11):3444-3451.
57. Liu B, Pop M (2009). Ardb-antibiotic resistance genes database. Nucleic Acids Res 37: D443-D447.
58. Lubick N (2009). India's drug problem. Nature 457(7230):640-641.
59. Martins AF, Vasconcelos TG, Henriques DM, Frank CD, Konig A, Kummerer K (2008). Concentration of ciprofloxacin in Brazilian hospital effluent and preliminary risk aassessment: A case study. Clean-Soil Air Water 36(3):264-269.
60. Mason M (2009). World's highest drug levels entering india stream. Associated Press. Retrieved from http://www.washingtontimes.com/news/2009/jan/26/worlds-highest-druglevel s- entering-india-stream/.
61. McDaniel LD, Young E, Delaney J, Ruhnau F, Ritchie KB, Paul JH (2010). High frequency of horizontal gene transfer in the oceans. Science 330(6000):50.
62. McManus PS, Stockwell VO, Sundin GW, Jones AL (2002). Antibiotic use in plant agriculture. Annu Rev Phytopathol 40:443-465. 500.
63. Metzker ML (2010). Sequencing technologies-The next generation. Nat Rev Genet 11(1): 31-46.
64. Ohlsen K, Ternes T, Werner G, Wallner U, Loffler D, Ziebuhr W, Witte W, Hacker J (2003). Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environ Microbiol 5(8):711-716.
65. Partridge SR, Tsafnat G, Coiera E, Iredell JR (2009). Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev 33(4):757-784.
66. Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, Esposito K, Stinson B (2010). Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol 44(13):4910-4916.
67. Riesenfeld CS, Goodman RM, Handelsman J (2004). Uncultured soil bacteria are a reservoir of new antibiotic resistance genes. Environ Microbiol 6(9):981-989.
68. Segura PA, Francois M, Gagnon C, Sauve S (2009). Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters. Environ Health Perspect 117 (5):675-684.
69. Skold O (2000). Sulfonamide resistance: Mechanisms and trends. Drug Resis Updat 3(3): 155-160.
70. Sommer MOA, Dantas G, Church GM (2009). Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325(5944):1128-1131.
71. Swedish Medical Product Agency (2009). Report on government commission regarding possibilities to require stricter environmental standards during the manufacturing of pharmaceuticals including active substances. In Rapport fra°n lakemedelsverket, December 16, 2009 [in Swedish with english summary]. Available at: http://www. Lakemedelsverket. Se/upload/nyheter/2009/2009-12-16_rapport_miljokrav-lakemedel.pdf.
72. Thomulka KW, Mcgee DJ, Lange JH (1993). Detection of biohazardous materials in water by measuring bioluminescence reduction with the marine organism Vibrioharveyi. J Environ Sci Health A Environ Sci Eng Toxic Hazard Subst Control 28(9):2153-2166.
73. Toleman MA, Bennett PM, Walsh TR (2006). Iscr elements: Novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev 70(2):296-316.
74. Tringe SG, von Mering C, Kobayashi A, Salamov AA, Chen K, Chang HW, Podar M, Short JM, Mathur EJ, Detter JC, Bork P, Hugenholtz P, Rubin EM (2005). Comparative metagenomics of microbial communities. Science 308(5721):554-557.
75. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (7122):1027-1031.
76. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI (2009). A core gut microbiome in obese and lean twins. Nature 457(7228):480-U487.
77. Wise R (2002). Antimicrobial resistance: Priorities for action. J Antimicrob Chemother 49 (4):585-586.
78. Yim G, de La Cruz F, Spiegelman GB, Davies J (2006). Transcription modulation of Salmonella enterica serovar typhimurium promoters by sub-mic levels of rifampin. J Bacteriol 188(22):7988-7991.
79. Zhang XX, Zhang T, Fang H (2009). Antibiotic resistance genes in water environment. Appl Microbiol Biotechnol 82(3):397-414.